These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9548454

  • 1. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.
    Levisetti MG, Padrid PA, Szot GL, Mittal N, Meehan SM, Wardrip CL, Gray GS, Bruce DS, Thistlethwaite JR, Bluestone JA.
    J Immunol; 1997 Dec 01; 159(11):5187-91. PubMed ID: 9548454
    [Abstract] [Full Text] [Related]

  • 2. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
    Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB.
    J Immunol; 1995 Aug 01; 155(3):1165-74. PubMed ID: 7543517
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ.
    Transplantation; 2001 Jun 15; 71(11):1656-65. PubMed ID: 11435979
    [Abstract] [Full Text] [Related]

  • 5. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
    Li ZL, Xue WJ, Tian PX, Ding XM, Tian XH, Feng XS, Hou J.
    Transplant Proc; 2007 Dec 15; 39(10):3436-7. PubMed ID: 18089400
    [Abstract] [Full Text] [Related]

  • 6. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 7. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF, Lin H, Wei RQ, Turka LA.
    J Heart Lung Transplant; 1996 Sep 01; 15(9):928-35. PubMed ID: 8889989
    [Abstract] [Full Text] [Related]

  • 8. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
    Baliga P, Chavin KD, Qin L, Woodward J, Lin J, Linsley PS, Bromberg JS.
    Transplantation; 1994 Nov 27; 58(10):1082-90. PubMed ID: 7526493
    [Abstract] [Full Text] [Related]

  • 9. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM, Nickerson PW, Restifo AC, Ivis-Woodward MA, Patel A, Allen RD, Strom TB, O'Connell PJ.
    J Immunol; 1997 Sep 01; 159(5):2232-9. PubMed ID: 9278311
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
    Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT.
    Transplantation; 1995 May 15; 59(9):1313-8. PubMed ID: 7762068
    [Abstract] [Full Text] [Related]

  • 11. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.
    Bolling SF, Lin H, Wei RQ, Linsley P, Turka LA.
    J Surg Res; 1994 Jul 15; 57(1):60-4. PubMed ID: 8041150
    [Abstract] [Full Text] [Related]

  • 12. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
    Kimura F, Gotoh M, Tanaka T, Luo Z, Miyazaki J, Uede T, Monden M, Miyasaka M.
    Diabetologia; 2002 Jun 15; 45(6):831-40. PubMed ID: 12107727
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis.
    McIntosh KR, Linsley PS, Drachman DB.
    Cell Immunol; 1995 Nov 15; 166(1):103-12. PubMed ID: 7585970
    [Abstract] [Full Text] [Related]

  • 14. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 15. [Preoperative inoculation of CTLA4Ig combined with allogeneic dendritic cells prolongs rat renal allograft survival in a donor-specific fashion].
    Harada H.
    Hokkaido Igaku Zasshi; 1999 May 15; 74(3):189-98. PubMed ID: 10422563
    [Abstract] [Full Text] [Related]

  • 16. Local CTLA4Ig synergizes with one-dose anti-LFA-1 to achieve long-term acceptance of pancreatic islet allografts.
    Chahine AA, Yu M, McKernan M, Stoeckert C, Linsley PS, Lau HT.
    Transplant Proc; 1994 Dec 15; 26(6):3296. PubMed ID: 7998139
    [No Abstract] [Full Text] [Related]

  • 17. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D, Li J, Orosz CG, Bumgardner GL.
    Hepatology; 2000 Nov 15; 32(5):1018-28. PubMed ID: 11050052
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
    Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA.
    Science; 1992 Aug 07; 257(5071):789-92. PubMed ID: 1323143
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
    Takayama T, Morelli AE, Robbins PD, Tahara H, Thomson AW.
    Gene Ther; 2000 Aug 07; 7(15):1265-73. PubMed ID: 10918497
    [Abstract] [Full Text] [Related]

  • 20. CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model.
    Roy-Chaudhury P, Nickerson PW, Manfro RC, Zheng XX, Steiger J, Li YS, Strom TB.
    Transplantation; 1997 Jul 15; 64(1):172-5. PubMed ID: 9233722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.